1
Efficacy and Safety of Stannsoporfin in Neonates
Condition(s):Nutritional and Metabolic DiseasesLast Updated:October 29, 2019Completed
Stannsoporfin: 14 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Follow up Study of Patients Having Participated in Clinical Trial 64,185-204
Condition(s):Hyperbilirubinemia, NeonatalLast Updated:February 2, 2021Completed
3
Long-Term Clinical Follow-Up of Children Enrolled in Stannsoporfin Clinical Trial Protocol No. 64,185-06-2(W)
Condition(s):HyperbilirubinemiaLast Updated:October 15, 2019Terminated
4
Stannsoporfin With Light Therapy for Newborn Babies With Jaundice
Condition(s):Jaundice, Neonatal; Hyperbilirubinemia, NeonatalLast Updated:February 6, 2020Completed
5
Compassionate Use of Stanate (TM) [Stannsoporfin]
Condition(s):Neonatal Jaundice; HyperbilirubinemiaLast Updated:October 15, 2019No longer available
6
Safety and Pharmacology of Stanate
Condition(s):HyperbilirubinemiaLast Updated:October 15, 2019Completed
7
A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia
Condition(s):Hyperbilirubinemia, NeonatalLast Updated:October 30, 2019Terminated
8
Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)
Condition(s):Jaundice; Neonatal HyperbilirubinemiaLast Updated:October 15, 2019Completed
9
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
Condition(s):Glucosephosphate Dehydrogenase Deficiency; Hyperbilirubinemia; Hemolytic Disease of NewbornLast Updated:June 24, 2005Completed
10
Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns
Condition(s):HyperbilirubinemiaLast Updated:September 9, 2008Completed